Incyte Corporation INCY

122.92 (1.90) (1.52%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

30.39% 29.87% 30.82% 30.67%
ROA
20.96% 20.75% 21.88% 23.55%
ROIC
52.81% 58.55% 61.52% 60.50%
Return on Tangible Assets
31.80% 30.35% 30.37% 29.73%
Average Days of Receivables
67.94 72.73 71.59 70.57
Free Cash Flow per Share
5.99 6.81 7.13 9.43
Free Cash Flow
1,172.04 1,329.63 1,420.88 1,890.47
Capital Expenditures
(79.37) (83.87) (95.90) (89.24)
Piotroski F-Score
9.00 9.00 8.00 6.00
Other line items
Cash ROIC
15.40% 15.15% 14.70% 17.33%
Accounts Receivable Turnover
5.82 5.48 5.72 5.91
Accounts Payable Turnover
1.94 1.83 1.90 1.75
Inventory Turnover
4.41 4.65 4.49 4.39
Average Days of Payables
184.87 205.92 206.83 212.72
Days of Inventory on Hand
89.73 99.12 104.60 95.61
Tax Rate
(0.25) (0.23) (0.19) (0.18)
Research and Development Expense of Revenue
39.58% 39.88% 39.71% 36.96%
Selling, General and Administrative Expense of Revenue
27.27% 26.77% 25.72% 24.05%
Share Based Compensation of Revenue
5.38% 4.85% 4.71% 4.38%
Interest Coverage
653.65 623.91 689.26 764.90
Operating CF/Net income
1.05 1.10 1.06 1.23
Depreciation/Fixed assets
0.12 0.13 0.13 0.14
Capex/Depreciation
(0.86) (0.90) (1.01) (0.91)
Revenue per Share
24.60 26.34 26.89 29.04
Operating CF per Share
6.40 7.24 7.61 9.88
Capex per Share
(0.41) (0.43) (0.48) (0.45)
Capex to Sales
0.02 0.02 0.02 0.02

Fold the line items

Columns are period end dates